14.03.2017 • NewsElaine BurridgeNexeoNexeo Solutions

Nexeo Solutions to Acquire Mexico’s Ultra Chem

(c) Lichtmeister/Shutterstock
(c) Lichtmeister/Shutterstock

Nexeo Solutions has agreed to acquire Mexican specialty chemicals distributor Ultra Chem for an undisclosed sum. Based in Mexico City, Ultra Chem represents major global producers both in Mexico and Latin America.

 “Acquiring Ultra Chem is aligned with our strategic objectives and accomplishes two goals. It expands our overall specialty mix and extends our chemical reach into Mexico,” said David Bradley, president and CEO of Nexeo Solutions. “Ultra Chem is a strong cultural fit with complementary end markets and current margins that are immediately accretive.”

The transaction, which is subject to the usual closing conditions and regulatory approvals, is expected to close during the second quarter of 2017. Nexeo said the agreement was facilitated through a proprietary deal process.

Earlier this month, Nexeo appointed Dan Smith as its new chairman, replacing Wilbur Ross who resigned as a result of his confirmation as US Secretary of Commerce. One of Ross’s key priorities is to renegotiate the NAFTA trade agreement with Mexico and Canada. In an interview with US television channel Fox News on Mar. 12, Ross said the Trump administration has yet to determine what the replacement agreement would look like. He said the department’s goal is to update the trade deal because the current version is “outdated” and has “wrong” features.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.